FDA Approved: MONOFERRIC — Supplemental Application (Pharmacosmos Therapeutics Inc.)

View source ↗

Summary

FDA approves a supplemental application for MONOFERRIC (ferric derisomaltose) from Pharmacosmos Therapeutics Inc., resulting in changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Deficiency Anemia

Drugs mentioned

• MONOFERRIC (FERRIC DERISOMALTOSE)

Snippet

SUPPL AP for MONOFERRIC (FERRIC DERISOMALTOSE)